RECORD ion HR AUNIING YAN I? Bl NG FOR PROVISIONALLY RES eae Teor PRARMACIST ONCOLOGY PHARMACY SERVICESPERSONAL PARTICULARS (TO BE COMPLETED BY PROVISIONALLY REGISTERED PHARMACIST- PRP) Name (in capital letter) N VC Number s Provisional Registration Number : cal Telephone Number a Home Address a E-mail Address : ~ . Qualification (Degree/ University/ Year) : » Scholarship/ Sponsor (Federal/ MARA/ Others) 2 Principal Training Place : 10. Duration of Training: From (date): etO eeccseeeceseeeeeres 11. Name & Contact Number of Person in case of emergency I confirm that the above information are true. Signature : Date : Name :Oncology Pharmacy Services ONCOLOGY PHARMACY SERVICES (Duration of Attachment: 4 weeks) 1. Knowledge of aseptic techniques, principles of cytotoxic cabinet and clean room design, types of protective gowning procedures, room differential pressure, calculations, solubility and compatibility problems, cytotoxic spill procedures, maintenance of cytotoxic safety cabinets, quality assurance tests of aseptic suite, safe handling of cytotoxic drugs, incineration of cytotoxic waste (1,200 degrees Celsius). N Ability to read and comprehend patient's case notes. » Ability to assess patient suitability for chemotherapy and adjunct regime. 4. Ability to discuss with prescriber. a Calculation / worksheet. a . Reconstitution. N Patient monitoring counseling in the wardOncology Pharmacy Services SUOTESEABAXO Jo UOWOBEUEW S ebeig + uoneyodsuest BuucHUOW WHIEeH quowebeuey j!ds a1SEM 2IKO}OKK Jo [esOdsiq.* (Ada) jueudinb3 enyooioid jouuosieg —« sBnup aixo101Ko jo Bupuey ses v [eM 0} enodwe woy s9ysued | ‘amog /Beq 0 [eI Woy 49jsueI| a6uuiks 0} ajnog /6eq wou, soJsUELL 1 ssenbluyos} uoneindueW + [IA Woy UoNN}Os Brup BumespyIM + uo} Zepmod ur Brup o1xo10}Ko Bulureiu09 [eIA ay) 0} ]UENHP Guppy & amjog uoisryul 0} ainodue Woy oRn|os Grup Jo Buippy « io} 1opmod ur Brup a1xX0}014a Bulure|uoo einodwie ue oy uenqIp BuIppy ‘einoduie Woy uoAnjos Brup a1xo}0fo Jo [EMEP Buntno|n eanioeioig BUINOWOY Bunoig + Bulumog + Buysen pueH + sonbiuyoe) ondese Jo seidiouud € eoueunssy Aen « Woo uesio pue TeUIgeD oIXo}O}A0 Jo BulUuesiD Woo! UBIO pUE ToUIGED o1xo}O}K9 Jo BoUEUEIUIEW z uBjsep WOOL UeElo pue JeUIGeD 91Ko}OVKo Jo Seid/oULLd L ON 38x ~BuysnE ML eva | ON : 4o}da201q JO OWEN : poveg Buuresy ADIAYAS AOVINYVHd ADO 1IODNOOncology Pharmacy Services uonesipurequog (2) uosoesoyuy (p) ‘AyniqiBam (0) Ayonueupny (4) ‘Aseynuuoy Brup 1ey Aoeuueydsjod (9) uoeaynuap! Bucs) (a) soy ey) UI JON (2) - s10410 Buyjedg (e) — - suonduosaig oedosddeuy Aouenbes (p) ‘asoq (9) uoyeing (q) euipay (2) - — suewiBey ayeudosddeu} ‘eimeubisiequnog (p) doy g eumeubig (9) uonesng (q) Aouanbal4 (2) - suonduoseig eyo|d.woou| :suonusasoyuy jo adh, JOUOVed id queysissy :Sy J9N98q0 0 dud so smeis ., soydaoalg (a/sv/o) dud saquoselg uonuenieqy | uoguaniazu Na jo ainjeuBblg g eweN | jo snzeIS,, uonesjunuiuiog | yo edAL, JOON queneg | aed Jaquosaid ey) YIM UoneoIuNWWOD ysenbas Adesayjoweyp jo Buluseiog + (seseo 0z | M35M HW) SWIDSY LONAPGV GNV AdVYSHLOW3HS YO4 ALITISVLINS LN3lLVd SSASSV OL ALITISGV ©} NOILOSS oaOncology Pharmacy Services uoneoipurenuod (9) ul AyuaiBeu (0) 1onde10}uI (Pp) Ayo rouiny (a) ‘Aueinuuos Brup jexidsoy eu) ul ION (2) = Aoeuueydhjod (9) uoneoynuep! Guoin, (4) 1010 Bumjeds (2) - suonduoseig oyeudouddeuj fousnbe14 (p) asoq (9) uuoneung (q) aupipan (2) - — suawibery ajeudosddeul ‘eunjeuBisieyuno9 (p) doy g eunyeubig (9) uoyeing (a) Aouenbai4(e) - — suojduosesg eqe{dwioou} -suopuansdyul Jo edAL, JaUWOLied id jueisissy ‘Sv Jeniesqo ‘0 dud so smeis Joydaoa1g (d/Sv/o) dud Jaquosaig uoguensaju) | uoNuenss;u Ned jo ainjeubig g owen | yo smeys,, | ymuopeojunu0g| 40 adhL, 40 ON quaneg | eed z aaM Jequoseid 8y) YIM UoneoluNWCD ysenbes Adeseyjowisyp Jo Buluesiog (seseo oz :uIw) AWIOTY LONNPGY GNV AdVYSHLOWSHO NOs ALMIGVLINS LNSlLVd SSASSV OL ALIMIGV :} NOILOASOncology Pharmacy Services hy (0) Ayonuauiny (a) ‘Azejnusio} Brup jeydsoy ayy ulION (2) - S180 uoyesipurequog (2) uojoeieyu| (p) ——-AoeueYdAjog (9) uopeoynuep! Bucs) (q) Buljedg (e) — - suoyduoseig eyeudosddeu} fouanboss (p) 280g (9) uuonesng (q) eursipew (2) - — suewiBey eyeudosddeu) aimeuBisiayunog (p) doyo g eumeubis (0) uuoneing (4) fouenbe14 (2) - suonduoseig aye}duioou) :suoquenseyul jo dA, JOWOLSd tg quesissy :sy J8N198G0 :O dud Jo sme ,, 40jde20e1g (a/Sv/0) dud Jequoselg uogueniazu; | uojueniezuy Nea jo ainjeuBlg g eweN | jo snjeIS,, jo adh, JO ON quaneg | areg € 435M Joquoseid oy) YIM UoNeoJUNWWOD * ysenbeu Adeseyjowsyp jo Bulueeing (seseo oz :u!IN) SWID3SY LONNPGV GNV AdVYSHLOW3SHD 404 ALIMISVLINS LNSlLVd SSSSSV OL ALINISV ‘+ NOILOASOncology Pharmacy Services ‘Auai6aun (0) Ayonueyiny (a) Arejnuusoy Brup jeydsoy eu) ul yon (2) - ‘su0410 uoneoipurenuog (2) uonoeeui(p) ——»-AoeuueydAiog (9) uonteoynusp! Buca (@) Bunieds (2) - suonduosesg ereudosddeu Kauanbei (p) esoq (9) uoneung (q) eursipaw(e) - — suewiGey eyeudoiddeu| ‘eunjeuBisiajunog (p) doy g eameubis (0) uoneang (a) Kouenbes4 (2) - — suonduosesd ajeidwioou} rsuoqueasezuy Jo odkL, JeUOped td jUe\sissy ‘gv Jenlesqo :0 dud Jo SMRIS 4, 4ojdaoe1g (a/svio) dud dequoselg uojueniejuy | uonuenss;u NR jo oinjeubls g owen | yo smeis,, | ymuoneoiunuucg| 0 edé1, 40 ON queneg | aed vy MaaM Jequoseid ay) YIM UoNesIUNUOD * isenbas Adeseujowisyo jo Bulueaiog (seseo oz :uIIN) SWIDSY LONAPGV GNV AdVYSHLOWSHS YO4 ALMISVLINS LNAILVd SSASSV OL ALITIGV + NOLLOASOncology Pharmacy Services JOUOped id quejsissy :s¥ 42N188q0 :O dud Jo smeys, doydade1g (a/svio) uonesedald Na Jo oinjeubls gy oweN dud Jo snjeg, Out Uy Brg 91X0}0}K9 oy) eWIEN quened area - 435M Buryoayoueyunog (1!) lege ‘eeysyom (I) (SaSV9 02) LASHSMYOM / NOLLV1ND1W9 LASHSMYOM JO NOLLWavdadd *@ NOILDASOncology Pharmacy Services JeUlopied id jueysissy Sv JeMlesqo ‘0 dud Jo smejg, joydaoe1d (a/sv/o) uoperederg Nd Jo einjeuBis g eweN dud Jo sneyg, UL U| Brag d1xo}0)K9 ay) eWeN juened ayeq 2 M3SaM Bupjseyosaqunog (11) lege] ‘esysyom (1) (SASV9 02) LABHSMYOM / NOILV1ND1V9 LASHSMYOM JO NOILVaVdaed *@ NOILOASOncology Pharmacy Services JaUUo}ied id jueysissy :Sv Jeesqo :0 dud Jo smeig, Joydeseid (a/svio) uonesedesg Nd Jo ainjeubls g aweN dud Jo smyejs, UL Uy Brag I1xo}o}\9 oy WEN quaned areq € 435M Buryoayouayuno (1!) lage7 Jesyso (!) (S3SV9 02) LABHSMYOM / NOILLV1ND1V9 LASHSMYOM JO NOILWuvdaed ?@ NOILOASOncology Pharmacy Services JaUUOped id queysissy ‘gy Janlesqo :0 dud Jo snyeig, 4oydevald (a/sv/o) uopesedeig Nea Jo ainjeubis gy eweN dud J0 snje5, au Ul Brug 91X0}0}49 oy) eUeN quaned aqea vy NASM Bupjyoayosajunog (1!) lege yeeysom (!) (SaSV9 02) LASHSMYOM / NOILV1ND1V9 LASHSMYOM AO NOILWeVdadd *@ NOLLOAS 10Oncology Pharmacy Services JOWIONed td quejsissy ‘sy JaN@SqO :O dud Jo snjeis, = UoHesedaid Jo [2301 sojydaeig Jo eimpeuBis g owen (a/Sw/0) dud yo smeis, Brug jo owen uopesedeig Jo ON N/Y wEHe” ee | MSSM Joydaceid kq passasse eq Jsnw sseooid UoNNIsUODe! g ISA] IV 4 (SNOLLVUWdaud 02) NOILNLLLSNOD3Y *€ NOILOAS llOncology Pharmacy Services JOUUO}ed td quejsissy ‘sv JeAesqo :O dud jo snjeis, = UoHesedald Jo [e}0) 4ojdade1g jo ainyeuBls % eweN (d/sw/o) dud Jo snyeis, 6nig jo owen uopesedeig Jo ON N/Y Ene” evea 2 MaaM Jojdaoeid hq passasse aq jsnuu ssad0ud UoNMsUODeI g 1SeO| IY . (SNOILVUVdaed 02) NOLLNLILSNODSY *€ NOLLOAS 12Oncology Pharmacy Services JOUUOLOd td juejsissy :S¥ JOAIasqO :O dud 40 smie3s, = uonesedaig JO |e}0) 4oydade1g jo ainyeuBls % eweN (d/SV/O) dud jo snyeys, Brig jo owen uopeiedeig Jo ON N/¥ JueHed area € W3SM Joydaseud kq passasse eq Jsnu sse00/d UoANIN}SUODeI g ISEB] IY (SNOLLVUWdaud 02) NOILNLILSNODSY + NOLLOASOncology Pharmacy Services JOUOLOd id quejsissy :Sv JOAIOSqO :O dud 40 snie}s, = uoNesedailg jo |e}0) 40jda001g jo einjeubls g eweN (d/Sw/0) dud jo smeis, Brug jo owen uonesedaid Jo ON Nr quened aieg vy W3SM Joydaseud hq passasse aq ysnui ssad0ud uonMysuodel g 1SB2] IV. (SNOLLVYVd5ud 02) NOLLALILSNODSY :€ NOILOAS 14Oncology Pharmacy Services JOWIOLEd id queysissy :sy JEAI@SqO :O dud 30 snjeis, 4oydese1g Jo einyeuBis *g oweN (a/svio) dud so smejs, jsunog, Buyoyuow eseg N/a quened aed Buljesunog BuLo}U0W, | M3SM (SASV9 02) ONITASNNOD / ONINOLINOW LNAILVd *¥ NOLLOAS 15Oncology Pharmacy Services JOWUOLOd td quejsissy ‘sy JENESqO :O dad 40 sn3e3s, 4oydese1g Jo einjeubls »g een (d/sv/o) dud Jo smje3s, Jesuno5 BuyopuoW seg Na quened aed Buyjesunog BuLsoyUopy @ M3SM (SASV9 02) ONITASNNOD / ONIMOLINOW LNAILWd = NOLLOSS 16Oncology Pharmacy Services Jewloyied id quejsissy Sv Jenresgo :O dud so smeys, 40jde9e1q jo (a/svio) aimeuBls 9 eweN | dud Jo smyeIS, Buljesunog Buyoyuow seg Nrawuened | eed € M3SM Buyesunog (1!) Bunoyuow (1) (SaSV9 02) SNITASNNOD / ONIMOLINOW LNAILVd :¥ NOILOSS 17Oncology Pharmacy Services JOUUOPSd id quejsissy :sy JeN@SqO :O dud Jo snjejs, 4oydese1g jo aimeuBig 9 euleN (a/svio) dud so smejs, jesuneg Buyoy1uow esea Nf juened aed Buljasuncg (1!) Buoyuop) (1) vy W3SM (SASV9 02) ONMIASNNOD / ONINOLINOW LNAILWd ‘7 NOILOAS 18Oncology Pharmacy Services ASSESSMENTOncology Pharmacy Services Suonesenesixe Jo jueweBeUEW 9 anbiuysey andese Jo uoneplien. s eBei01g + uoneyodsuelt BuuoWuoW YNeeH quowebeury ids 282M 2IKO}O}K J Jesedsiq.* (add) juowdnba exnoooid jeuUosied sGnup 21x0}0149 Jo Bulpuey oes y Je 0} enodwe woy soysuel, @mog /Beq 0} je1A wos sojsueL]« ‘@buyAs 0} ajog /Beq wou) s9jsuelL + ‘senbjuyse} uoneinduew, lets woy uonnios Grup Bumespuni —« wos Jepmod ul Bnup o1X0}0K9 BulUle|uoo jeIA ey) 0} JUeNYP BuIppy + ‘en}0g UoIsNyUt 0} ainoduwe wos} UoHINIOS Brup jo Bulppy iio 1apmod U! Grup oKo}oKo BuUjeWUOD einodwe ue o} yeNIp Bulppy * ‘einoduse Wosj UONNIOS Brup o1Ko}OVK0 Jo EMEIPUIIM& BuIMio19 enntosioig BunoWery BuAcD + Buumoy + Bulysem pur + senbjuysey ondase jo saidioutid € eoueunssy Ayjen* loos ueEpp pue oUIgeD o}xo}O}Ao Jo BulUee|D woo, ueal9 pue youlges 21xo}0K9 Jo BOUEUAIUIEW z UuBIsep Wood Ues|o pUE JeUIGeD o1KoIOKKO Jo Se/dioULLg L ESUCITIT) waxeuiy SySeL wea | ON SOURUUOHOd JO Epes 3903 1MON» NO LNAWSSASSY 'S NOILDAS 20Oncology Pharmacy Services Se0|M19s /SIJUN AJoA9 JO} %OQ UCL} SS9] JOU Pinoys yeW % °Z BO1AJBS UN JUJO O} GYd SU} SJEUIWASsIp Oo} }YBIJ Sey s10j9JEU} (da) fewdsoy ey) UI sysioeWueUg Jo peasy /Jo}dadelq [ediouUg au) ‘|elIdsoY 9U} UI a{GEIIEAR JOU S| DIAIES BUT J] “1 ‘LON seimeubig g eweN sioj\deoe1g AGNLILLY NO LNAWWOS WHANS9 ‘2 NOILOAS a6pe|mouy uo yuswssessy Buljesunoo / Bul jow yuaned uomjsuosey, yeaysyiom Jo uonesedelg awiBes ounlpe pue Adeseujowieyo 40 Ayygeyns queyed ssesse 0} Ayiay syuewu09 VN v € z L yseL @OURUUO}IEg JO |2Ae] ANAWSSASSV LNAL3dWO9 :9 NOILOAS 21Oncology Pharmacy Services % ov 001 X “MEV TWLOL Buljasunos / Buyoyuow yuaned uonnysuosey yeaysyiom / uoneINg|eD awi6ad younlpe pue Adesayjowayo 40} Ayjiqeyins juayed ssasse 0} Aiiqy abpajmouy Jo Juawssessy ainjeubig g SoweN $Jo}deoalg syuawiwo0d BOURUOLad (p=xew) SOURUOLed jo apeig ON AFONVWYOIYAd 40 AYVWWNS 22PHARMACY BOARD MALAYSIA. AINA g sa eC eM NE ORO Sag PTSL Oa Van (chL ALN SELANGOR, MALAYSIA CORRESPONDENCE ADDRESS : LOCKED MAILBAG NO.924 SN Ua \eelaa(ed 46790 PETALING JAYA SELANGOR, MALAYSIA